Roche公司的口服抗肿瘤药capecitabine（商品名Zeoda）有可能用于治疗转移性乳腺癌。在这一多中心Ⅱ期临床研究中有162例用传统疗法难以治疗的转移性乳腺癌妇女。结果ZO％的本品接受者的肿瘤大小缩小了50％以上，少数妇女得以完全缓解。43例耐紫杉醇和耐一种惠环类药物的乳腺癌 Roche’s oral antitumor drug capecitabine (trade name Zeoda) may be used to treat metastatic breast cancer. In this multicenter Phase II clinical study, there were 162 women with metastatic breast cancer who were refractory to traditional therapies. Results The tumor size of ZO% of the recipients of this product was reduced by more than 50%, and a small number of women were able to achieve complete remission. 43 cases of breast cancer resistant to paclitaxel and a kind of benefit ring